This project finances the construction of a new pharmaceutical production plant and installation of fully automated equipment, with a maximum capacity of 280 million plastic ampoules of injectables.
Mutabar Medical Standart LLC is a newly established company in Uzbekistan specifically for the Project implementation. The Borrower is 100 per cent owned by Jurabek Laboratories LLC, the "Sponsor", which is the largest local pharmaceutical production company in Uzbekistan.
The remaining financing for this project is being provided by Jurabek Laboratories.
«Mutabar Medical Standart» LTD, Porloq street, Tashkent, Uzbekistan
ACCOUNTABILITY MECHANISM OF EBRD
The Project Complaint Mechanism (PCM) is the independent complaint mechanism and fact-finding body for people who have been or are likely to be adversely affected by an European Bank for Reconstruction and Development (EBRD)-financed project. If you submit a complaint to the PCM, it may assess compliance with EBRD's own policies and procedures to prevent harm to the environment or communities or it may assist you in resolving the problem that led to the complaint through a dialogue with those implementing the project. Additionally, the PCM has the authority to recommend a project be suspended in the event that harm is imminent. You can contact the PCM at email@example.com or you can submit a complaint online using an online form, http://www.ebrd.com/eform/pcm/complaint_form?language=en. You can learn more about the PCM and how to file a complaint at http://www.ebrd.com/work-with-us/project-finance/project-complaint-mechanism.html.